Vitaspring Biomedical annual ebitda margin
2018
2019
2020
2021
2022
Vitaspring Biomedical EBITDA Margin Growth & History (VSBC)
Vitaspring Biomedical's ebitda margin was 20.22% for fiscal 2022.
View full Vitaspring Biomedical company overviewVitaspring Biomedical annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-01-31 | 20.22% | −151.17 pp |
| 2021 | 2021-01-31 | 171.39% | +122.71 pp |
| 2020 | 2020-01-31 | 48.67% | +176.41 pp |
| 2019 | 2019-01-31 | −127.74% | −90.78 pp |
| 2018 | 2018-01-31 | −36.96% | — |
Vitaspring Biomedical quarterly ebitda margin
Q1.19
Q1.20
Q2.20
Q4.21
Q3.22
Q1.23
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q1 2023 | 2022-04-30 | 23.28% | — |
| Q3 2022 | 2021-10-31 | 70.61% | — |
| Q4 2021 | 2021-01-31 | 227.85% | — |
| Q2 2020 | 2019-07-31 | −151.75% | — |
| Q1 2020 | 2019-04-30 | −116.40% | −157.29 pp |
| Q1 2019 | 2018-04-30 | 40.89% | — |
Vitaspring Biomedical ebitda margin trends
Between the periods ended 2018-01-31 and 2022-01-31, Vitaspring Biomedical's ebitda margin increased from −36.96% to 20.22%, a change of +57.18 percentage points. The latest reported quarter, Q1 2023, shows 23.28%.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vitaspring Biomedical source filings ↗